Drug General Information
Drug ID	D04ICN
Former ID	DIB010768
Drug Name	DuP-630
Indication	Dermatitis [ICD9: 692.9; ICD10:L20-L30]		Terminated	[545582]
Company	Bristol-Myers Squibb Pharma Co
Structure		Download 2D MOL 3D MOL
Canonical SMILES	C(C(n1cncc1)C)(c1ccc(cc1)F)(c1ccc(cc1)F)O
CAS Number	CAS 128104-27-8
Target and Pathway
Target(s)	Cytochrome P450 reductase	Target Info	Modulator	[550870]
BioCyc Pathway	Superpathway of tryptophan utilization
	Superpathway of melatonin degradation
	Melatonin degradation I
	Vitamin D<sub>3</sub> biosynthesis
	Bile acid biosynthesis, neutral pathway
WikiPathways	Oxidation by Cytochrome P450
References
Ref 545582	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003777)
Ref 550870	CN patent application no. 1096855, Composition produced by treatment and induction of nitrogen mono oxide synthase expressed matter, and use thereof.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.